Skip to main content
Utility Menu
Contact
Helpful Links
News and Notices
Français
Login
Provinces
Canadian Pharmacy Regulatory Authorities
AB
BC
MB
NB
NL
NS
NT
NU
ON
PE
QC
SK
YT
All
Search
Main navigation
About
Expand/Collapse About
Pharmacy Regulation In Canada
Annual Reports
NAPRA Governance
Strategic Plan
National Drug Schedules
Expand/Collapse National Drug Schedules
Drug Scheduling in Canada
NDS Process and Scheduling Factors
NAPRA NDS Policies
NDS Notice Board
Application for Drug Scheduling
National Drug Scheduling Advisory Committee
Drug Scheduling External Liaison Group (DSELG)
Practice and Regulatory Standards
Expand/Collapse Practice and Regulatory Standards
Pharmacists
Pharmacy Technicians
General Practice Resources
Policies and Positions
Programs and Services
Expand/Collapse Programs and Services
National Model Licensing Program - Pharmacists
Pharmacists’ Gateway Canada
Pilot Program to Prepare for Practical Training (P4T)
Online Pharmacies
National Statistics
News and Notices
Login
Français
Provinces
Canadian Pharmacy Regulatory Authorities
AB
BC
MB
NB
NL
NS
NT
NU
ON
PE
QC
SK
YT
All
Menu
Main navigation
About
Expand/Collapse About
Pharmacy Regulation In Canada
Annual Reports
NAPRA Governance
Board of Directors
Advisory Committees
Strategic Plan
National Drug Schedules
Expand/Collapse National Drug Schedules
Drug Scheduling in Canada
NDS Process and Scheduling Factors
Implementation of the National Drug Schedules
NAPRA NDS Policies
NDS Notice Board
Application for Drug Scheduling
By-law No. 2 and Rules of Procedure
Drug Scheduling Fees
National Drug Scheduling Advisory Committee
Committee Membership
Committee Members
Confidentiality and Conflict of Interest
Meeting Schedule
Meeting Minutes
Drug Scheduling External Liaison Group (DSELG)
Practice and Regulatory Standards
Expand/Collapse Practice and Regulatory Standards
Pharmacists
Pharmacy Technicians
General Practice Resources
Policies and Positions
Programs and Services
Expand/Collapse Programs and Services
National Model Licensing Program - Pharmacists
Pharmacists’ Gateway Canada
Pilot Program to Prepare for Practical Training (P4T)
Online Pharmacies
National Statistics
News and Notices
Français
Search
Search
Contact
National Drug Schedules (NDS) Updates
Subscribe
Breadcrumb
Home
»
News and Notices
»
National Drug Schedule Updates
Share
on Twitter
on Facebook
on LinkedIn
via email
Keywords
Search
News Type
No term selected
NAPRA Updates
National Drug Schedules (NDS) Updates
Practice Resources
July 28, 2021
Final Recommendations for Non-Live Recombinant Herpes Zoster Vaccine and Bisacodyl 5mg Tablets
July 22, 2021
NDSAC Meeting of September 19-20, 2021
June 30, 2021
Fixed-Dose Combination Acetaminophen and Ibuprofen Schedule Clarification
June 15, 2021
NDSAC Interim Recommendations on Non-Live Recombinant Herpes Zoster Vaccine and Bisacodyl 5mg Tablets
June 2, 2021
Ephedrine and Pseudoephedrine to Remain on the NAPRA National Drug Schedules Until 2024
April 8, 2021
National Drug Scheduling Advisory Committee Virtual Meeting June 6 and 7, 2021
February 5, 2021
Invitation for Nominations for NAPRA’s National Drug Scheduling Advisory Committee
January 11, 2021
Clarification of Vaccine Scheduling in the National Drug Schedules
January 7, 2021
NDSAC Meeting of March 7-8, 2021
Get the latest on National Drug Schedules (NDS) Updates
Subscribe
